Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 228
Filter
1.
J Appl Microbiol ; 130(6): 2132-2140, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33090589

ABSTRACT

AIMS: Purine-degrading enzymes are favourable as medications and diagnostic tools for hyperuricemia. This study aimed to characterize enzymes isolated from micro-organisms, which may be useful for developing a new prophylaxis for hyperuricemia. METHODS AND RESULTS: Cellulosimicrobium funkei A153 was found to be a good catalyst for hypoxanthine degradation and could oxidize hypoxanthine to xanthine and further to uric acid. The enzyme catalysing this oxidation was purified, and its partial amino acid sequences were examined. Based on this information and genome sequencing results, this xanthine dehydrogenase family protein was cloned and expressed in Rhodococcus erythropolis L88. The recombinant enzyme with a His-tag was characterized. The enzyme was a xanthine oxidase as it could utilize molecular oxygen as an electron acceptor. It was stable under 50°C and exhibited maximum activity at pH 7·0. The kcat , Km and kcat /Km values for xanthine were 1·4 s-1 , 0·22 mmol l-1 and 6·4 s-1  mmol-1  l, respectively. CONCLUSIONS: Xanthine oxidase is favourable for hyperuricemia medication because it oxidizes hypoxanthine, an easily adsorbed purine, to xanthine and further to uric acid, which are hardly adsorbed purines. SIGNIFICANCE AND IMPACT OF THE STUDY: The enzyme is useful for decreasing serum uric acid levels via conversion of easily absorbed purines to hardly absorbed purines in the intestine. Enzymes from micro-organisms may be used as a novel prophylaxis for hyperuricemia.


Subject(s)
Actinobacteria/enzymology , Hypoxanthine/metabolism , Purines/metabolism , Rhodococcus/metabolism , Xanthine Oxidase/chemistry , Actinobacteria/genetics , Amino Acid Sequence , Bacterial Proteins , DNA, Bacterial , Oxidation-Reduction , Recombinant Proteins/metabolism , Rhodococcus/genetics , Uric Acid/metabolism , Whole Genome Sequencing , Xanthine/metabolism , Xanthine Dehydrogenase/metabolism , Xanthine Oxidase/genetics
2.
J Periodontal Res ; 53(5): 777-784, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29687443

ABSTRACT

BACKGROUND: There is rapidly developing interest into the role of several anti-inflammatory agents to resolve inflammation in periodontal disease. A bioactive polyunsaturated fatty acid, 10-oxo-trans-11-octadecenoic acid (KetoC), is known to have various beneficial physiological effects; however, the effect of KetoC on inflammation remains unclear. Here, we investigated the effect of KetoC on RAW 264.7 cells stimulated with Porphyromonas gingivalis lipopolysaccharide, and explored the intracellular mechanism responsible for its anti-inflammatory effects. METHODS: RAW 264.7 cells were pre-treated with or without KetoC, and then stimulated with or without P. gingivalis lipopolysaccharide. Levels of tumor necrosis factor α (TNFα), interleukin (IL)-6 and IL-1ß were determined by real-time polymerase chain reaction and enzyme-linked immunosorbent assay. Specific antagonists for G protein-coupled receptor (GPR)40 and GPR120 were used to clarify the receptor for KetoC. The intracellular mechanism was investigated using western blotting analysis to separate nuclear and cytosolic NF-κB p65 protein. RESULT: KetoC (5 µmol/L) was not toxic to RAW 264.7 cells, and significantly reduced the expression of TNFα and IL-6 mRNA and protein, and IL-1ß mRNA. No protein production of IL-1ß was observed. Additionally, when bound to GPR120, KetoC trended to downregulate nuclear NF-κB p65 protein levels. However, the antagonist for GPR40 failed to diminish the action of KetoC. CONCLUSION: KetoC suppressed the proinflammatory cytokines TNFα, IL-6 and IL-1ß via NF-κB p65, by binding to its receptor GPR120. KetoC is a promising candidate in future studies as a bioactive anti-inflammatory agent in treating periodontal disease.


Subject(s)
Anti-Inflammatory Agents , Lipopolysaccharides/adverse effects , Oleic Acids/pharmacology , Porphyromonas gingivalis , Animals , Inflammation Mediators/metabolism , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Mice , Oleic Acids/metabolism , Oleic Acids/therapeutic use , Periodontal Diseases/drug therapy , RAW 264.7 Cells , Receptors, G-Protein-Coupled/metabolism , Transcription Factor RelA/metabolism , Tumor Necrosis Factor-alpha/metabolism
3.
J Appl Microbiol ; 120(5): 1282-8, 2016 May.
Article in English | MEDLINE | ID: mdl-26855315

ABSTRACT

AIMS: This study aims to produce hydroxy fatty acids efficiently. METHODS AND RESULTS: Escherichia coli overexpressing linoleic acid Δ9 hydratase from Lactobacillus plantarum AKU 1009a was employed to produce hydroxy fatty acids with industrial potential. We found that 280 g l(-1) of linoleic acid (1 mol l(-1)) was converted into (S)-10-hydoxy-cis-12-octadecenoic acid (HYA) with a high conversion rate of 98% (mol/mol) and more than 99·9% enantiomeric excess (e.e.) by recombinant E. coli cells in the presence of FAD and NADH. In the same way, many kinds of C18 unsaturated fatty acids with Δ9 carbon double bond (280 g l(-1)) were converted into corresponding 10-hydroxy fatty acids with the conversion rates over 95% (mol/mol). We also produced HYA at a high rate of accumulation (289 g l(-1) ) with a high yield (97 mol%) in a reaction mixture that contained glucose instead of NADH. CONCLUSIONS: We developed a process for producing several types of hydroxy fatty acids with high accumulation rates and high yields. SIGNIFICANCE AND IMPACT OF THE STUDY: Hydroxy fatty acids are important materials for the chemical, food, cosmetic and pharmaceutical industries, and thus they have recently attracted much interest in a variety of research fields. However, the mass production of hydroxy fatty acids has been limited. This method of hydroxy fatty acids production will facilitate the widespread application of hydroxy fatty acids in various industries.


Subject(s)
Fatty Acids/biosynthesis , Hydroxy Acids/metabolism , Lactobacillus plantarum/enzymology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Escherichia coli/genetics , Escherichia coli/metabolism , Lactobacillus plantarum/genetics , Linoleic Acid/metabolism , Organisms, Genetically Modified/metabolism
4.
Eur J Clin Nutr ; 69(6): 693-6, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25669318

ABSTRACT

BACKGROUND/OBJECTIVES: Xeroderma pigmentosum (XP) is a rare autosomal recessive disease characterized by defective repair of ultraviolet (UV) irradiation-induced DNA damage and high risk of skin cancer. Thus, these patients require strict photoprotection. Considering the importance of UV-mediated cutaneous vitamin D production, such rigorous photoprotection would cause vitamin D deficiency. Then, we have studied the vitamin D status in patients with XP-A, a group requiring the most strict photoprotection. SUBJECTS/METHODS: Twenty-one patients with XP-A (aged 6-25) were evaluated for their vitamin D intake, serum levels of 25-hydroxy-vitamin D (25OHD) and parathyroid hormone (PTH). Vitamin D intake was assessed by a 2-day food weighing method. RESULTS: Median dietary intake of vitamin D was 4.1 µg/day, and the median concentrations of serum 25OHD and PTH were 7.7 and 49.9 pg/ml, respectively. In 76% of the patients, serum 25OHD level was lower than 10 ng/ml, indicating vitamin D deficiency. Vitamin D intake and serum 25OHD level were significantly lower in patients under enteral nutrition (EN) than those with oral intake (OI). Multivariate analyses revealed that EN was a significant predictor of decreased serum 25OHD level (ß coefficient=-0.59, P=0.03). CONCLUSIONS: Vitamin D deficiency is highly prevalent in XP-A patients, and supplementation should be considered to avoid unfavorable skeletal consequences in these patients. In addition, determination of dietary vitamin D requirement has been a difficult work issue in the decision of dietary reference intakes (DRIs) because of its cutaneous production. Data from XP patients would yield useful information for the determination of DRIs for vitamin D.


Subject(s)
Life Style , Nutritional Status , Patient Compliance , Skin Neoplasms/prevention & control , Sunscreening Agents/therapeutic use , Vitamin D Deficiency/etiology , Xeroderma Pigmentosum/therapy , 25-Hydroxyvitamin D 2/blood , Adolescent , Adult , Calcifediol/blood , Child , Combined Modality Therapy/adverse effects , Cross-Sectional Studies , Female , Hospitals, University , Humans , Japan/epidemiology , Male , Outpatient Clinics, Hospital , Parathyroid Hormone/blood , Prevalence , Risk , Skin Neoplasms/etiology , Sunscreening Agents/adverse effects , Vitamin D Deficiency/epidemiology , Xeroderma Pigmentosum/blood , Xeroderma Pigmentosum/physiopathology , Young Adult
5.
J Appl Microbiol ; 118(3): 641-7, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25495454

ABSTRACT

AIM: To find cis-11-eicosenoic acid (20:1ω9, EA)-producing micro-organisms. METHODS AND RESULTS: We found EA-producing fungi by screening about 300 fungal strains and identified a major fatty acid accumulated in the Mortierella fungi as EA by means of GC-MS analysis. In particular, Mortierella chlamydospora CBS 529.75 produced a high amount of EA (36.3 mg g(-1) of dried cells) on cultivation at 28°C for 4 days and then at 12°C for 3 days. In the result of lipid analysis, most of the EA was a component of triacylglycerols, not phospholipids. CONCLUSION: We found that M. chlamydospora CBS 529.75 was the best producer for the microbial production of EA. SIGNIFICANCE AND IMPACT OF THE STUDY: EA is beneficial as a raw material for medical supplies and a moisturizing component of cosmetic creams. This is the first report of microbial production of EA.


Subject(s)
Fatty Acids, Monounsaturated/metabolism , Mortierella/metabolism , Fatty Acids, Monounsaturated/analysis , Lipids/analysis , Mortierella/chemistry , Triglycerides/chemistry
6.
Dis Esophagus ; 27(5): 479-84, 2014 Jul.
Article in English | MEDLINE | ID: mdl-22989274

ABSTRACT

Identification of reliable markers of radiosensitivity and the key molecules that donate susceptibility to anticancer treatments to esophageal cancer cells would be highly desirable. We found that the mRNA expression of insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) was higher in radioresistant TE-5 and TE-9 cells than in radiosensitive TE-12 cloneA1 cells. Conversely, knocking down expression of IGF2BP3 mRNA in TE-5 and TE-9 cells using small interfering RNA significantly enhanced their radiosensitivity. Furthermore, patients with squamous cell esophageal cancers strongly expressing IGF2BP3 tended to respond poorly to chemoradiation. These data suggest that IGF2BP3 may be a key marker of radiosensitivity that diminishes the susceptibility of squamous cell esophageal cancer cells to radiotherapy. IGF2BP3 may, thus, be a useful target for improving radiotherapy for patients with esophageal squamous cell carcinoma.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Esophageal Neoplasms/metabolism , RNA-Binding Proteins/genetics , Radiation Tolerance/genetics , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/radiotherapy , Cell Line, Tumor , Chemoradiotherapy , Esophageal Neoplasms/pathology , Esophageal Neoplasms/radiotherapy , Gene Knockdown Techniques , Humans , RNA, Messenger/metabolism , RNA, Small Interfering , RNA-Binding Proteins/metabolism
7.
Lett Appl Microbiol ; 55(6): 414-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22967283

ABSTRACT

An Fe(II)/α-ketoglutarate-dependent dioxygenase, SadA, was obtained from Burkholderia ambifaria AMMD and heterologously expressed in Escherichia coli. Purified recombinant SadA had catalytic activity towards several N-substituted l-amino acids, which was especially strong with N-succinyl l-leucine. With the NMR and LC-MS analysis, SadA converted N-succinyl l-leucine into N-succinyl l-threo-ß-hydroxyleucine with >99% diastereoselectivity. SadA is the first enzyme catalysing ß-hydroxylation of aliphatic amino acid-related substances and a potent biocatalyst for the preparation of optically active ß-hydroxy amino acids.


Subject(s)
Burkholderia/enzymology , Dioxygenases/metabolism , Escherichia coli/metabolism , Leucine/analogs & derivatives , Leucine/biosynthesis , Succinates/metabolism , Burkholderia/genetics , Dioxygenases/genetics , Escherichia coli/genetics , Hydroxylation/genetics , Ketoglutaric Acids/chemistry , Ketoglutaric Acids/metabolism , Leucine/chemistry , Leucine/metabolism , Oxidation-Reduction , Succinates/chemistry
8.
Kyobu Geka ; 65(8): 682-6, 2012 Jul.
Article in Japanese | MEDLINE | ID: mdl-22868428

ABSTRACT

In cancer patients, cerebrovascular disease is recognized as the 2nd most common complication involving the central nervous system. Once cancer occurs in stroke patients, or vice versa, neurological outcomes significantly worsen and prognosis tends to be poor. Perioperative stroke after noncardiac, nonneurosurgical procedures is more common than generally acknowledged. It is reported to have an incidence of 0.05~7.4% of patients. "The analysis of lung cancer registry for resected cases in 1994", jointly established by the Japan Lung Cancer Society and the Japanese Association for Chest Surgery, reported a 2.4% frequency of cerebrovascular disease. Cerebrovascular disease is an unavoidable comorbidity for thoracic surgeons. Most are thrombotic in origin and are noted after discharge from the postanesthetic care unit. The mortality is more than 2 times greater than in strokes occurring outside the hospital. Delayed diagnosis and a synergistic interaction between the inflammatory changes normally associated with stroke, and those normally occurring after surgery, may explain this increase. Emergency non-contrast scanning of the brain is the primary diagnostic brain imaging study for evaluation of patients with suspected stroke, and the goal is to complete the computer tomography examination within 25 min of the provisional diagnosis being made.


Subject(s)
Cerebrovascular Disorders/complications , Thoracic Surgical Procedures/methods , Humans , Lung Neoplasms/surgery
9.
Dis Esophagus ; 25(3): 228-34, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21895851

ABSTRACT

Patients who have received subtotal esophagectomy for thoracic esophageal cancer must be closely monitored for second primary malignancies. The purpose of this study is to review and assess patients who developed a second primary esophageal cancer in the residual cervical esophagus. Between 1996 and 2010, 10 patients were diagnosed in our hospital with esophageal squamous cell cancer in the residual cervical esophagus after undergoing thoracic esophagectomy and were treated with endoscopic or surgical resection. Data from these patients were reviewed retrospectively. Seven of the 10 patients (70%) had multiple primary carcinoma lesions at the time of their esophagectomy. A second primary cancer in the residual cervical esophagus was detected in eight patients during follow-up endoscopic examinations while the patients were still asymptomatic. Seven of the patients underwent endoscopic resection for a superficial cancer. None of those patients experienced any complications, and all are currently alive and cancer-free. The remaining three patients underwent resection of the cervical esophagus with regional lymph node dissection. Two of those patients experienced severe complications; one subsequently died (hospital death) from pneumonia, 12 months after surgery, while the other died from recurrence of his cancer. The third patient is alive and cancer-free. Early detection of a second primary malignancy in the residual cervical esophagus followed by endoscopic resection is the best treatment strategy for patients who previously received subtotal esophagectomy for thoracic esophageal cancer. Surgical resection puts patients at high risk of mortality or morbidity.


Subject(s)
Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/surgery , Esophageal Neoplasms/surgery , Neoplasms, Second Primary/pathology , Neoplasms, Second Primary/surgery , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/therapy , Chemoradiotherapy, Adjuvant , Esophagectomy/adverse effects , Esophagoscopy , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoplasms, Second Primary/therapy , Radiotherapy, Adjuvant , Retrospective Studies , Treatment Outcome
10.
Dis Esophagus ; 24(3): 166-71, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20946135

ABSTRACT

We investigated the effectiveness of chemoradiotherapy for the treatment of lymph node recurrence and hematogenous metastasis after esophagectomy for esophageal squamous cell carcinoma. Between 2001 and 2006, 216 patients with thoracic esophageal squamous cell carcinoma had curative esophagectomy. Of those, 23 with lymph node recurrence received chemoradiotherapy (50.0-68.8 Gy). In addition, five patients had isolated recurrences in a distant organ and received chemoradiotherapy (50.0-60.0 Gy). We analyzed outcomes from the radiotherapy for recurrent esophageal cancer. The 1-, 2-, and 5-year survival rates after recurrence for the 23 patients whose lymph node recurrence was treated with chemoradiotherapy were 52, 31, and 24%, respectively, and the median survival time was 13 months. Among the five patients with recurrent tumors in a distant organ, chemoradiotherapy produced a complete response in two patients, a partial response in one patient, and stable disease in two patients, giving an effectiveness rate of 60% (complete response + partial response). Chemoradiotherapy has a beneficial prognostic effect in patients with lymph node recurrence of esophageal squamous cell carcinoma. Chemoradiotherapy for a metastatic tumor in a distant organ may be the treatment of choice in cases where systemic chemotherapy has proven ineffective.


Subject(s)
Carcinoma, Squamous Cell/therapy , Esophageal Neoplasms/therapy , Aged , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/secondary , Combined Modality Therapy , Esophageal Neoplasms/mortality , Esophageal Neoplasms/pathology , Esophagectomy , Female , Humans , Kaplan-Meier Estimate , Liver Neoplasms/mortality , Liver Neoplasms/secondary , Liver Neoplasms/therapy , Lung Neoplasms/mortality , Lung Neoplasms/secondary , Lung Neoplasms/therapy , Lymphatic Metastasis , Male , Middle Aged , Recurrence , Survival Rate
11.
Eur Surg Res ; 45(1): 41-4, 2010.
Article in English | MEDLINE | ID: mdl-20733316

ABSTRACT

We report 2 cases of small cell carcinoma of the esophagus treated with esophagectomy as a primary treatment and following chemotherapy. One patient (pT1N1M0) achieved long-term survival, while the other patient (pT1N1M1-lym) died 18 months after surgery. We used reports on 47 Japanese patients receiving esophagectomy as a primary treatment to determine when esophagectomy for small cell carcinoma of the esophagus is indicated. We conclude that esophagectomy as a local treatment provides relatively good long-term survival only in patients without lymph node involvement.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Small Cell/drug therapy , Carcinoma, Small Cell/surgery , Esophageal Neoplasms/drug therapy , Esophageal Neoplasms/surgery , Esophagectomy/methods , Carcinoma, Small Cell/mortality , Carcinoma, Small Cell/pathology , Combined Modality Therapy , Esophageal Neoplasms/mortality , Esophageal Neoplasms/pathology , Fatal Outcome , Humans , Male , Middle Aged , Neoplasm Staging , Survivors , Treatment Outcome
12.
J Appl Microbiol ; 108(6): 2012-8, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19919619

ABSTRACT

AIMS: Optimal production conditions of conjugated gamma-linolenic acid (CGLA) from gamma-linolenic acid using washed cells of Lactobacillus plantarum AKU 1009a as catalysts were investigated. METHODS AND RESULTS: Washed cells of Lact. plantarum AKU 1009a exhibiting a high level of CGLA productivity were obtained by cultivation in a nutrient medium supplemented with 0.03% (w/v) alpha-linolenic acid as an inducer. Under the optimal reaction conditions with 13 mg ml(-1)gamma-linolenic acid as a substrate in 5 -ml reaction volume, the washed cells [32% (wet cells, w/v) corresponding to 46 mg ml(-1) dry cells] as the catalysts produced 8.8 mg CGLA per millilitre reaction mixture (68% molar yield) in 27 h. The produced CGLA was a mixture of two isomers, i.e., cis-6,cis-9,trans-11-octadecatrienoic acid (CGLA1, 40% of total CGLA) and cis-6,trans-9,trans-11-octadecatrienoic acid (CGLA2, 60% of total CGLA), and accounted for 66% of total fatty acid obtained. The CGLA produced was obtained as free fatty acids adsorbed mostly on the surface of the cells of Lact. plantarum AKU1009a. CONCLUSION: The practical process of CGLA production from gamma-linolenic acid using washed cells of Lact. plantarum AKU 1009a was successfully established. SIGNIFICANCE AND IMPACT OF THE STUDY: We presented the first example of microbial production of CGLA. CGLA produced by the process is valuable for evaluating their physiological and nutritional effects, and chemical characteristics.


Subject(s)
Industrial Microbiology , Lactobacillus plantarum/metabolism , alpha-Linolenic Acid/biosynthesis , gamma-Linolenic Acid/biosynthesis , Culture Media , Hydrogen-Ion Concentration , Temperature
13.
Bone Marrow Transplant ; 45(3): 565-9, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19633693

ABSTRACT

Fibrosis and excessive extracellular matrix production are characteristic features of lacrimal gland chronic GVHD (cGVHD). Tranilast (n-[3,4-anthoranilic acid]), used for fibrotic skin disease, inhibits transforming growth factor-beta-induced matrix production. We conducted a non-randomized study comparing 8 patients (five men, three women; median age, 47 years) given topical tranilast with 10 patients (three men, seven women; median age, 37 years) receiving therapy with topical artificial tears, sodium hyaluronate and vitamin A for mild ocular cGVHD. The tranilast group instilled topical tranilast and artificial tears q.i.d., beginning the day of dry eye diagnosis. The ocular surface and tear dynamics of each patient were evaluated before hematopoietic stem cell transplant, at the onset of dry eye and after 3 months of treatment. At 3 months, the scores of the Rose Bengal test and Schirmer test with nasal stimulation had significantly improved in the tranilast group compared with that in the control group (P<0.05). Furthermore, although five control patients (50%) developed severe dry eye within the treatment period, only one tranilast-treated patient (12.5%) did; the rest still had mild dry eye (P<0.05). These results suggest the hypothesis that topical tranilast may effectively retard the progression of mild dry eye associated with cGVHD.


Subject(s)
Dry Eye Syndromes/drug therapy , Dry Eye Syndromes/etiology , Graft vs Host Disease/complications , ortho-Aminobenzoates/administration & dosage , Adult , Anti-Allergic Agents/administration & dosage , Chronic Disease , Dry Eye Syndromes/physiopathology , Female , Graft vs Host Disease/etiology , Hematologic Neoplasms/therapy , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Male , Middle Aged , Ophthalmic Solutions , Tears/metabolism
14.
J Appl Microbiol ; 106(5): 1697-704, 2009 May.
Article in English | MEDLINE | ID: mdl-19226396

ABSTRACT

AIMS: Bio-process development for isomer selective and efficient production of cis-9,trans-11-octadecadienoic acid (CLA) from trans-vaccenic acid (t-VA, trans-11-octadecenoic acid) through microbial fatty acid Delta9-desaturation reaction. METHODS AND RESULTS: A total of 550 strains of fungi and yeasts were screened for CLA production from t-VA through Delta9 desaturation. Delacroixia coronata IFO 8586 was selected as a potent producer of CLA from t-VA. Efficient CLA production was observed during cultivation in medium supplemented with the methyl ester of t-VA (t-VAME). Under the optimal conditions with 33.3 mg ml(-1) of t-VAME as substrate, 10.5 mg ml(-1) CLA was produced by D. coronata IFO 8586 after 7 days of cultivation in the medium containing dextrin (5.0%), tryptone (2.0%) and thiourea (0.83 micromol ml(-1)). The strain produced the cis-9,trans-11 isomer of CLA selectively (98% of total CLA), with a small amount of the trans-9,trans-11 isomer (2% of total CLA), mainly in the form of triacylglycerols (69% of total CLA). CONCLUSIONS: A practical bio-process for selective production of cis-9,trans-11 isomer of CLA using filamentous fungus D. coronata IFO 8586 was successfully established. SIGNIFICANCE AND IMPACT OF THE STUDY: Isomer selective bio-process for the practical production of cis-9,trans-11-CLA was first established. The process is benefitable for expanding the application of CLA for medicinal and nutraceutical purposes.


Subject(s)
Fungi/metabolism , Linoleic Acids, Conjugated/metabolism , Oleic Acids/metabolism , Culture Media , Hydrogen-Ion Concentration , Isomerism , Linoleic Acids, Conjugated/chemistry , Oleic Acids/chemistry , Temperature , Time Factors
15.
Kyobu Geka ; 62(8 Suppl): 728-32, 2009 Jul.
Article in Japanese | MEDLINE | ID: mdl-20715700

ABSTRACT

The sentinel node (SN) concept is that lymphatic flux from a primary tumor initially flows into the SN. If this concept is correct, and metastasis is not found in a SN, it almost certainly that metastasis is not present in more distal lymph nodes. SN mapping and biopsy were developed as techniques for staging the lymphatic basin without the potential morbidity of lymph edema and nerve injury in cases of melanoma, or lymph edema of the arm in cases of breast cancer. Although there is also evidence of the existence of SN in non-small cell lung cancer (NSCLC), SN mapping is not widely used in the treatment of NSCLC. The potential benefit of SN mapping in NSCLC is enabling surgeons to know more precise staging of cancer. More sensitive techniques can be employed with a limited amount of tissue to detect micrometastasis. In addition, SN mapping can be applied to appropriate segmentectomy for NSCLC.


Subject(s)
Lung Neoplasms/pathology , Sentinel Lymph Node Biopsy/methods , Humans
16.
Kyobu Geka ; 61(11): 920-6, 2008 Oct.
Article in Japanese | MEDLINE | ID: mdl-18939426

ABSTRACT

Twenty-one cases of tracheo-bronchoplasty were performed in Akita University Hospital from 1997 to 2007. There are 14 cases of squamous cell carcinoma, 3 cases of adenocarcinoma, 2 cases of adenoid cystic carcinoma, 1 case of inflammatory tracheal stenosis, and 1 case of inflammatory bronchial stenosis. We performed 12 cases of right upper sleeve lobectomy, 4 cases of left upper sleeve lobectomy, 2 cases of left lower sleeve lobectomy, 1 case of right sleeve pneumonectomy, and 2 cases of tracheoplasty. Of 3 cases, we added sleeve resection of pulmonary artery. The ends of the bronchus are anastomosed end-to-end. The bronchial anastomotic suture was carried out peri-cartilaginously through all layers using an interrupted suture technique except for membranous portion. Membranous portion was sutured a continuous anastomotic technique. We use monofilament, absorbable suture material.


Subject(s)
Adenocarcinoma/surgery , Bronchi/surgery , Carcinoma, Adenoid Cystic/surgery , Carcinoma, Squamous Cell/surgery , Lung Neoplasms/surgery , Plastic Surgery Procedures/methods , Pneumonectomy/methods , Trachea/surgery , Tracheal Stenosis/surgery , Adult , Aged , Anastomosis, Surgical , Female , Humans , Male , Suture Techniques
17.
Eur Surg Res ; 41(3): 279-83, 2008.
Article in English | MEDLINE | ID: mdl-18600026

ABSTRACT

BACKGROUND: Thanks to significant recent progress in the application of chemoradiotherapy (CRT) in the treatment of esophageal cancer, the numbers of operations on patients who have undergone preoperative CRT are increasing. In these patients, preoperative CRT often leads to formation of an unstable, scleroid layer comprised of what appears to be scar tissue around the tracheobronchial wall. This scleroid layer must be removed with the tumor, thereby weakening the wall. METHOD: We performed preventive intrathoracic transposition of a pedicled latissimus dorsi muscle flap on 6 patients with clinically T4 esophageal cancer (6 males; age: 63-75 years). All 6 patients had undergone preoperative CRT (median, 43.0 Gy; range, 32.0-60.0 Gy; with cisplatin + 5-fluorouracil infusion) to relieve direct invasion of the airway. RESULTS: In 6 patients, preventive use of a pedicled latissimus dorsi muscle flap resulted in uneventful recovery from the tracheobronchial wall weakness. Anastomotic leakage, recurrent nerve paralysis and pneumonia occurred in 2 patients each (33.3%); there were no life-threatening complications or operation-related deaths, however. CONCLUSIONS: When performing an esophagectomy for thoracic esophageal squamous-cell cancer in patients who have received preoperative CRT, the weakened tracheobronchial wall can potentially be reinforced using a pedicled latissimus dorsi muscle flap.


Subject(s)
Esophageal Neoplasms/surgery , Esophageal Neoplasms/therapy , Esophagectomy/methods , Surgical Flaps , Aged , Antineoplastic Combined Chemotherapy Protocols , Bronchi/surgery , Cisplatin/administration & dosage , Combined Modality Therapy , Fluorouracil/administration & dosage , Humans , Male , Middle Aged , Muscle, Skeletal/surgery , Trachea/surgery
18.
Anaesthesia ; 62(7): 648-53, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17567338

ABSTRACT

Lung injury, including pneumonia, can occur in the early postoperative period following thoracic surgery. Pulmonary oxygen consumption is thought to increase in patients with pulmonary infection. This study measured oxygen consumption in relationship to lung injury in the early postoperative period after thoracic surgery. Thirty-five patients who underwent thoraco-abdominal oesophagectomy for oesophageal cancer were studied. Measured oxygen-consumption was obtained by indirect calorimetry and calculated oxygen-consumption was simultaneously determined by the reverse Fick method. The difference in oxygen consumption was attributed to pulmonary oxygen consumption. The difference in oxygen consumption increased to 23.1 ml.min(-1).m(-2) on postoperative day 2. In patients with pneumonia the difference in oxygen consumption increased significantly to 39.0 ml.min(-1).m(-2) the day before clinical onset of pneumonia, and it increased further to 65.7 ml.min(-1).m(-2) on the day that pneumonia became clinically apparent. These findings suggest that the difference in oxygen consumption may be useful for estimating the extent of lung injury and for predicting pulmonary complications in the postoperative period.


Subject(s)
Esophagectomy , Oxygen Consumption , Pneumonia/physiopathology , Postoperative Complications/physiopathology , Aged , Calorimetry, Indirect , Esophageal Neoplasms/surgery , Female , Humans , Male , Middle Aged , Pneumonia/diagnosis , Postoperative Complications/diagnosis , Postoperative Period , Prognosis , Pulmonary Gas Exchange
19.
Dis Esophagus ; 20(1): 42-6, 2007.
Article in English | MEDLINE | ID: mdl-17227309

ABSTRACT

Loss of voice after total laryngectomy is a major concern that has prompted much effort to develop methods of surgical voice restoration. In 1992, Kawahara described a tracheocolic shunt for voice restoration using a revascularized ileocolic graft. With this method, aspiration through the phonatory shunt is prevented by the ileocolic valve (Bauhin's valve), while vocalization is allowed. The purpose of this study was to use sound spectrogram analysis to evaluate voices surgically restored in that way. Between 2002 and 2005, 10 consecutive patients underwent laryngopharyngoesophagectomy with Kawahara's surgical voice restoration for advanced carcinoma of the hypopharynx and/or cervical esophagus at Akita University Hospital, Japan. We then used sound spectrography to analyze and compare the voices of patients receiving Kawahara's voice restoration, against healthy volunteers and patients who underwent the same surgery without voice restoration and spoke using an electronic larynx. We also evaluated the intelligibility of conversation and performed a listening test. The sound spectrograms showed that when produced by the electronic larynx, consonant sounds and voice frequencies below 300 Hz were not clearly recognized. By contrast, in patients who received Kawahara's surgical voice restoration, consonant and vowel sounds at frequencies above and below 300 Hz were clearly recognized. Although conversation was intelligible with both Kawahara's surgical voice restoration and the electronic device, listeners judged the voice produced by the former to be superior. Thus, the voice produced by Kawahara's surgical voice restoration is superior to that produced by the electronic larynx.


Subject(s)
Carcinoma/surgery , Esophageal Neoplasms/surgery , Hypopharyngeal Neoplasms/surgery , Sound Spectrography , Speech Intelligibility , Aged , Anastomosis, Surgical , Carcinoma/pathology , Case-Control Studies , Colon/transplantation , Esophageal Neoplasms/pathology , Esophagectomy , Female , Humans , Hypopharyngeal Neoplasms/pathology , Ileum/transplantation , Laryngectomy , Larynx, Artificial , Male , Middle Aged , Pharyngectomy , Speech, Alaryngeal
20.
Eur Surg Res ; 39(1): 7-13, 2007.
Article in English | MEDLINE | ID: mdl-17106200

ABSTRACT

Pulmonary edema is the most frequent postoperative complication following esophagectomy for thoracic esophageal cancer. We enrolled 23 patients who underwent esophagectomy with extended lymph node dissection for thoracic esophageal cancer in a prospective observational clinical trial. We used the PiCCO device to measure extravascular lung water with the aim of determining whether it correlates with the respiratory index and whether it is predictive of pulmonary complications. Based on constant criteria, the tracheal tubes of 11 patients were removed on the morning of postoperative day 1 (extubation group), while 12 patients remained intubated (intubation group). These two groups significantly differed in that all patients in the extubation group recovered without any pulmonary complications, whereas 4 patients (33%) in the intubation group developed pulmonary complications. The extravascular lung water measured using PiCCO correlated significantly with the respiratory index. In the intubation group, both extravascular lung water and respiratory index were elevated 12 h after surgery and were even higher 24 h after surgery. The extravascular lung water measured using PiCCO reflects the level of postoperative pulmonary edema and predicts the pulmonary complications induced by esophagectomy with extended lymph node dissection.


Subject(s)
Carcinoma, Squamous Cell/surgery , Esophageal Neoplasms/surgery , Esophagectomy/adverse effects , Extravascular Lung Water/metabolism , Pulmonary Edema/diagnosis , Thermodilution/methods , Aged , Female , Humans , Lymph Node Excision , Male , Middle Aged , Postoperative Complications/diagnosis , Postoperative Complications/metabolism , Predictive Value of Tests , Pulmonary Edema/etiology , Pulmonary Edema/metabolism , Respiration, Artificial , Respiratory Function Tests , Thermodilution/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL
...